Pacira BioSciences (PCRX) Other Gross PP&E Adjustments: 2011-2025
Historic Other Gross PP&E Adjustments for Pacira BioSciences (PCRX) over the last 14 years, with Sep 2025 value amounting to $221.5 million.
- Pacira BioSciences' Other Gross PP&E Adjustments fell 3.05% to $221.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $917.7 million, marking a year-over-year increase of 4.87%. This contributed to the annual value of $250.9 million for FY2024, which is 1.07% up from last year.
- According to the latest figures from Q3 2025, Pacira BioSciences' Other Gross PP&E Adjustments is $221.5 million, which was down 4.87% from $232.8 million recorded in Q2 2025.
- In the past 5 years, Pacira BioSciences' Other Gross PP&E Adjustments registered a high of $250.9 million during Q4 2024, and its lowest value of $147.3 million during Q1 2021.
- Over the past 3 years, Pacira BioSciences' median Other Gross PP&E Adjustments value was $221.5 million (recorded in 2025), while the average stood at $220.9 million.
- In the last 5 years, Pacira BioSciences' Other Gross PP&E Adjustments surged by 57.25% in 2021 and then dropped by 3.05% in 2025.
- Over the past 5 years, Pacira BioSciences' Other Gross PP&E Adjustments (Quarterly) stood at $197.2 million in 2021, then grew by 16.67% to $230.1 million in 2022, then grew by 7.86% to $248.2 million in 2023, then climbed by 1.07% to $250.9 million in 2024, then fell by 3.05% to $221.5 million in 2025.
- Its last three reported values are $221.5 million in Q3 2025, $232.8 million for Q2 2025, and $212.5 million during Q1 2025.